ArticleJournal of neuro-oncology2025

Effects of re-challenge with temozolomide in grade 2/3 IDH mutant gliomas at first progression.

Lalanthica V Yogendran et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.